Colombia plans to regulate cannabis-derived medications, allowing pharmacies to sell controlled-dose forms like tablets and creams. Only authorized pharmacies may prepare custom prescriptions. Agencies will oversee...
Hesse’s slow cannabis club licensing—averaging nine months—frustrates applicants and burdens clubs financially. Many fail due to bureaucracy, high costs, and unclear rules. Despite legalization, access remains...
Kazakhstan has legalized low-THC hemp cultivation, aiming to produce high-security paper for export. Strict regulations limit THC to 0.3%. Production will center in North Kazakhstan, with...
Medical cannabis imports in Germany have surged, but health insurance-covered prescriptions remain low. Easy online access raises concerns about abuse and bypassing doctor contact. Proposed reforms...
Germany plans stricter rules for medical cannabis: prescriptions will require in-person doctor visits, banning video consultations and mail-order delivery. Sales will be limited to pharmacies to...
Switzerland is moving toward cannabis legalization with a public health-focused bill. Adults could buy certified marijuana from licensed outlets, grow up to three plants, and face...
A U.S. cannabis company is using Dogecoin (DOGE) as part of its financial reserves, aiming to blend innovation with flexibility. DOGE’s low fees, fast transactions, and...
Ten cannabis clubs in Hesse, Germany, have received approval to legally cultivate marijuana under strict regulations. Despite broader access, youth interest is declining. A Frankfurt study...
Aurora Cannabis faces market pressure despite strong international sales and record recent results. Its cautious 2026 outlook makes the stock speculative and suited for risk-tolerant investors....
The ninth "Mary Jane" hemp fair broke records with over 500 exhibitors and 20,000 square meters of space. Fueled by partial cannabis legalization, attendance surged despite...